Table of Contents Europe Insulin Like Growth Factor I Market Report 2012-2023 1 Insulin Like Growth Factor I Overview 1.1 Product Overview and Scope of Insulin Like Growth Factor I 1.2 Classification of Insulin Like Growth Factor I by Product Category 1.2.1 Europe Insulin Like Growth Factor I Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Europe Insulin Like Growth Factor I Sales (K Units) Market Share by Types in 2017 1.2.3 CIGB-845 1.2.4 Dusigitumab 1.2.5 GM-6 1.2.6 M-610.27 1.2.7 M-630 1.2.8 Others 1.3 Europe Insulin Like Growth Factor I Market by Application/End Users 1.3.1 Europe Insulin Like Growth Factor I (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Alzheimer's Disease 1.3.3 Breast Cancer 1.3.4 Huntington Disease 1.3.5 Muscular Dystrophy 1.3.6 Others 1.4 Europe Insulin Like Growth Factor I Market by Region 1.4.1 Europe Insulin Like Growth Factor I Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Germany Status and Prospect (2012-2023) 1.4.3 UK Status and Prospect (2012-2023) 1.4.4 France Status and Prospect (2012-2023) 1.4.5 Russia Status and Prospect (2012-2023) 1.4.6 Benelux Status and Prospect (2012-2023) 1.4.7 Italy Status and Prospect (2012-2023) 1.4.8 Spain Status and Prospect (2012-2023) 1.5 Europe Sales and Revenue ofSales and Revenue of Insulin Like Growth Factor I (2012-2023) 1.5.1 Europe Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Europe Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Insulin Like Growth Factor I 2.2 Raw Material Analysis of Insulin Like Growth Factor I 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Insulin Like Growth Factor I 2.4 Other Costs Analysis of Insulin Like Growth Factor I 2.5 Manufacturing Cost Structure Analysis of Insulin Like Growth Factor I 2.6 Manufacturing Process Analysis of Insulin Like Growth Factor I 2.7 Raw Materials Sources of Insulin Like Growth Factor I Major Manufacturers in 2018 2.8 Downstream Buyers 3 Europe Insulin Like Growth Factor I Players/Suppliers Profiles and Sales Data 3.1 Boehringer Ingelheim GmbH 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Insulin Like Growth Factor I Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Boehringer Ingelheim GmbH Different Types of Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Volume in Different Applications and Its Application Share 3.2 Genervon Biopharmaceuticals LLC 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Insulin Like Growth Factor I Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Genervon Biopharmaceuticals LLC Different Types of Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Volume in Different Applications and Its Application Share 3.3 MedImmune LLC 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Insulin Like Growth Factor I Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 MedImmune LLC Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 MedImmune LLC Different Types of Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 MedImmune LLC Insulin Like Growth Factor I Volume in Different Applications and Its Application Share 3.4 Regulaxis SAS 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Insulin Like Growth Factor I Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Regulaxis SAS Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Regulaxis SAS Different Types of Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Regulaxis SAS Insulin Like Growth Factor I Volume in Different Applications and Its Application Share 3.5 ... 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Insulin Like Growth Factor I Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 ... Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 ... Different Types of Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 ... Insulin Like Growth Factor I Volume in Different Applications and Its Application Share 4 Europe Insulin Like Growth Factor I Competition by Players/Manufacturers, Region, Type and Application 4.1 Europe Insulin Like Growth Factor I Market Competition by Players/Manufacturers 4.1.1 Europe Insulin Like Growth Factor I Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Europe Insulin Like Growth Factor I Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Europe Insulin Like Growth Factor I Sales and Revenue by Type 4.2.1 Europe Insulin Like Growth Factor I Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Europe Insulin Like Growth Factor I Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Europe Insulin Like Growth Factor I Sales and Revenue by Application 4.3.1 Europe Insulin Like Growth Factor I Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Europe Insulin Like Growth Factor I Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Europe Insulin Like Growth Factor I Sales (K Units) by Application 5 Germany Insulin Like Growth Factor I (Sales, Revenue and Price) 5.1 Germany Insulin Like Growth Factor I Sales and Value (2012-2017) 5.1.1 Germany Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Germany Insulin Like Growth Factor I Revenue and Growth Rate (2012-2017) 5.1.3 Germany Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017) 5.2 Germany Insulin Like Growth Factor I Sales (K Units) and Market Share by Type 5.3 Germany Insulin Like Growth Factor I Sales (K Units) and Market Share by Application 6 UK Insulin Like Growth Factor I (Sales, Revenue and Price) 6.1 UK Insulin Like Growth Factor I Sales and Value (2012-2017) 6.1.1 UK Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017) 6.1.2 UK Insulin Like Growth Factor I Revenue and Growth Rate (2012-2017) 6.1.3 UK Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017) 6.2 UK Insulin Like Growth Factor I Sales (K Units) and Market Share by Type 6.3 UK Insulin Like Growth Factor I Sales (K Units) and Market Share by Application 7 France Insulin Like Growth Factor I (Sales, Revenue and Price) 7.1 France Insulin Like Growth Factor I Sales and Value (2012-2017) 7.1.1 France Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017) 7.1.2 France Insulin Like Growth Factor I Revenue and Growth Rate (2012-2017) 7.1.3 France Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017) 7.2 France Insulin Like Growth Factor I Sales (K Units) and Market Share by Type 7.3 France Insulin Like Growth Factor I Sales (K Units) and Market Share by Application 8 Russia Insulin Like Growth Factor I (Sales, Revenue and Price) 8.1 Russia Insulin Like Growth Factor I Sales and Value (2012-2017) 8.1.1 Russia Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Russia Insulin Like Growth Factor I Revenue and Growth Rate (2012-2017) 8.1.3 Russia Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017) 8.2 Russia Insulin Like Growth Factor I Sales (K Units) and Market Share by Type 8.3 Russia Insulin Like Growth Factor I Sales (K Units) and Market Share by Application 9 Benelux Insulin Like Growth Factor I (Sales, Revenue and Price) 9.1 Benelux Insulin Like Growth Factor I Sales and Value (2012-2017) 9.1.1 Benelux Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017) 9.1.2 Benelux Insulin Like Growth Factor I Revenue and Growth Rate (2012-2017) 9.1.3 Benelux Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017) 9.2 Benelux Insulin Like Growth Factor I Sales (K Units) and Market Share by Type 9.3 Benelux Insulin Like Growth Factor I Sales (K Units) and Market Share by Application 10 Italy Insulin Like Growth Factor I (Sales, Revenue and Price) 10.1 Italy Insulin Like Growth Factor I Sales and Value (2012-2017) 10.1.1 Italy Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Italy Insulin Like Growth Factor I Revenue and Growth Rate (2012-2017) 10.1.3 Italy Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017) 10.2 Italy Insulin Like Growth Factor I Sales (K Units) and Market Share by Type 10.3 Italy Insulin Like Growth Factor I Sales (K Units) and Market Share by Application 11 Spain Insulin Like Growth Factor I (Sales, Revenue and Price) 11.1 Spain Insulin Like Growth Factor I Sales and Value (2012-2017) 11.1.1 Spain Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Spain Insulin Like Growth Factor I Revenue and Growth Rate (2012-2017) 11.1.3 Spain Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017) 11.2 Spain Insulin Like Growth Factor I Sales (K Units) and Market Share by Type 11.3 Spain Insulin Like Growth Factor I Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Europe Insulin Like Growth Factor I Market Forecast (2018-2023) 13.1 Europe Insulin Like Growth Factor I Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Europe Insulin Like Growth Factor I Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Europe Insulin Like Growth Factor I Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Europe Insulin Like Growth Factor I Price and Trend Forecast (2018-2023) 13.2 Europe Insulin Like Growth Factor I Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Europe Insulin Like Growth Factor I Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Europe Insulin Like Growth Factor I Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 Germany Insulin Like Growth Factor I Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 UK Insulin Like Growth Factor I Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 France Insulin Like Growth Factor I Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Russia Insulin Like Growth Factor I Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 France Insulin Like Growth Factor I Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Italy Insulin Like Growth Factor I Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Spain Insulin Like Growth Factor I Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Europe Insulin Like Growth Factor I Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Europe Insulin Like Growth Factor I Sales Forecast by Type (2018-2023) 13.3.2 Europe Insulin Like Growth Factor I Revenue Forecast by Type (2018-2023) 13.3.3 Europe Insulin Like Growth Factor I Price Forecast by Type (2018-2023) 13.4 Europe Insulin Like Growth Factor I Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Europe Market Size (Million USD) Comparison 2012-2023 Table Europe Market Insulin Like Growth Factor I Revenue (Million USD) Comparison by Regions 2012-2023 Table Europe Insulin Like Growth Factor I Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Europe Insulin Like Growth Factor I Sales (K Units) by Application (2016-2023) Figure Product Picture of Insulin Like Growth Factor I Table Europe Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Europe Insulin Like Growth Factor I Sales (K Units) Market Share by Types in 2017 Figure CIGB-845 Picture Figure Dusigitumab Picture Figure GM-6 Picture Table Europe Insulin Like Growth Factor I Sales (K Units) Comparison by Applications (2012-2023) Figure Europe Sales Market Share of Insulin Like Growth Factor I by Applications in 2017 Figure Alzheimer's Disease Picture Figure Breast Cancer Picture Figure Huntington Disease Picture Table Europe Market Insulin Like Growth Factor I Revenue (Million USD) Comparison by Regions 2012-2023 Figure Germany Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023) Figure UK Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023) Figure France Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023) Figure Russia Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023) Figure Benelux Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023) Figure Italy Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023) Figure Spain Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2023) Figure Europe Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Insulin Like Growth Factor I Table Industry News List of Insulin Like Growth Factor I Figure Industry Chain Structure of Insulin Like Growth Factor I Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Insulin Like Growth Factor I in 2017 Figure Manufacturing Process Analysis of Insulin Like Growth Factor I Table Raw Materials Sources of Insulin Like Growth Factor I Major Manufacturers Europe Table Major Buyers of Insulin Like Growth Factor I Table Boehringer Ingelheim GmbH Basic Information List Table Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales Growth Rate (2012-2017) Figure Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017) Figure Boehringer Ingelheim GmbH Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017) Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Boehringer Ingelheim GmbH Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share Table Boehringer Ingelheim GmbH Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share Table Boehringer Ingelheim GmbH Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share Table Genervon Biopharmaceuticals LLC Basic Information List Table Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales Growth Rate (2012-2017) Figure Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017) Figure Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017) Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share Table Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share Table Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share Table MedImmune LLC Basic Information List Table MedImmune LLC Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure MedImmune LLC Insulin Like Growth Factor I Sales Growth Rate (2012-2017) Figure MedImmune LLC Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017) Figure MedImmune LLC Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017) Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table MedImmune LLC Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share Table MedImmune LLC Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share Table MedImmune LLC Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share Table Regulaxis SAS Basic Information List Table Regulaxis SAS Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Regulaxis SAS Insulin Like Growth Factor I Sales Growth Rate (2012-2017) Figure Regulaxis SAS Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017) Figure Regulaxis SAS Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017) Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Regulaxis SAS Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share Table Regulaxis SAS Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share Table Regulaxis SAS Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share Table ... Basic Information List Table ... Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure ... Insulin Like Growth Factor I Sales Growth Rate (2012-2017) Figure ... Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017) Figure ... Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017) Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table ... Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share Table ... Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share Table ... Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share Table Basic Information List Table Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Insulin Like Growth Factor I Sales Growth Rate (2012-2017) Figure Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017) Figure Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017) Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share Table Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share Table Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share Table Basic Information List Table Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Insulin Like Growth Factor I Sales Growth Rate (2012-2017) Figure Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017) Figure Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017) Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share Table Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share Table Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share Table Basic Information List Table Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Insulin Like Growth Factor I Sales Growth Rate (2012-2017) Figure Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017) Figure Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017) Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share Table Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share Table Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share Table Basic Information List Table Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Insulin Like Growth Factor I Sales Growth Rate (2012-2017) Figure Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017) Figure Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017) Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share Table Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share Table Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share Table Company Basic Information List Table Company Insulin Like Growth Factor I Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Insulin Like Growth Factor I Sales Growth Rate (2012-2017) Figure Company Insulin Like Growth Factor I Sales Europe Market Share (%) (2012-2017) Figure Company Insulin Like Growth Factor I Revenue Europe Market Share (%) (2012-2017) Table CIGB-845 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dusigitumab Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GM-6 Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Insulin Like Growth Factor I Volume in Alzheimer's Disease and Its Application Share Table Company Insulin Like Growth Factor I Volume in Breast Cancer and Its Application Share Table Company Insulin Like Growth Factor I Volume in Huntington Disease and Its Application Share Table Europe Insulin Like Growth Factor I Sales (K Units) by Players/Manufacturers (2012-2017) Table Europe Insulin Like Growth Factor I Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Europe Insulin Like Growth Factor I Sales Market Share (%) by Players/Manufacturers Figure 2017 Europe Insulin Like Growth Factor I Sales Share by Players/Manufacturers Table Europe Insulin Like Growth Factor I Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Europe Insulin Like Growth Factor I Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Europe Insulin Like Growth Factor I Revenue Market Share (%) Players Figure 2017 Europe Insulin Like Growth Factor I Revenue Market Share (%) Players Table Europe Insulin Like Growth Factor I Sales (K Units) and Market Share (%) by Type (2012-2017) Table Europe Insulin Like Growth Factor I Sales Share by Type (2012-2017) Figure Sales Market Share of Insulin Like Growth Factor I by Type (2012-2017) Figure Europe Insulin Like Growth Factor I Sales Growth Rate (%) by Type (2012-2017) Table Europe Insulin Like Growth Factor I Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Europe Insulin Like Growth Factor I Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Insulin Like Growth Factor I by Type (2012-2017) Figure Europe Insulin Like Growth Factor I Revenue Growth Rate by Type (2012-2017) Table Europe Insulin Like Growth Factor I Sales (K Units) and Market Share by Regions (2012-2017) Table Europe Insulin Like Growth Factor I Sales Share by Regions (2012-2017) Figure Sales Market Share of Insulin Like Growth Factor I by Regions (2012-2017) Figure Europe Insulin Like Growth Factor I Sales Market Share by Regions in 2017 Table Europe Insulin Like Growth Factor I Revenue (Million USD) and Market Share by Regions (2012-2017) Table Europe Insulin Like Growth Factor I Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Insulin Like Growth Factor I by Regions (2012-2017) Figure Europe Insulin Like Growth Factor I Revenue Market Share by Regions in 2017 Table Europe Insulin Like Growth Factor I Sales (K Units) and Market Share by Application (2012-2017) Table Europe Insulin Like Growth Factor I Sales Share (%) by Application (2012-2017) Figure Europe Insulin Like Growth Factor I Sales Market Share by Application (2012-2017) Figure Europe Insulin Like Growth Factor I Sales Market Share by Application (2012-2017) Figure Germany Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) (2012-2017) Figure Germany Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Germany Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017) Table Germany Insulin Like Growth Factor I Sales (K Units) by Type (2012-2017) Table Germany Insulin Like Growth Factor I Sales (K Units) Market Share by Type (2012-2017) Figure Germany Insulin Like Growth Factor I Sales (K Units) Market Share by Type in 2017 Table Germany Insulin Like Growth Factor I Sales (K Units) by Applications (2012-2017) Table Germany Insulin Like Growth Factor I Sales (K Units) Market Share by Applications (2012-2017) Figure Germany Insulin Like Growth Factor I Sales (K Units) Market Share by Applications in 2017 Figure UK Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017) Figure UK Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure UK Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017) Table UK Insulin Like Growth Factor I Sales (K Units) by Type (2012-2017) Table UK Insulin Like Growth Factor I Sales (K Units) Market Share by Type (2012-2017) Figure UK Insulin Like Growth Factor I Sales (K Units) Market Share by Type in 2017 Table UK Insulin Like Growth Factor I Sales (K Units) by Applications (2012-2017) Table UK Insulin Like Growth Factor I Sales (K Units) Market Share by Applications (2012-2017) Figure UK Insulin Like Growth Factor I Sales (K Units) Market Share by Applications in 2017 Figure France Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017) Figure France Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure France Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017) Table France Insulin Like Growth Factor I Sales (K Units) by Type (2012-2017) Table France Insulin Like Growth Factor I Sales (K Units) Market Share by Type (2012-2017) Figure France Insulin Like Growth Factor I Sales (K Units) Market Share by Type in 2017 Table France Insulin Like Growth Factor I Sales (K Units) by Applications (2012-2017) Table France Insulin Like Growth Factor I Sales (K Units) Market Share by Applications (2012-2017) Figure France Insulin Like Growth Factor I Sales (K Units) Market Share by Applications in 2017 Figure Russia Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017) Figure Russia Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Russia Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017) Table Russia Insulin Like Growth Factor I Sales (K Units) by Type (2012-2017) Table Russia Insulin Like Growth Factor I Sales (K Units) Market Share by Type (2012-2017) Figure Russia Insulin Like Growth Factor I Sales (K Units) Market Share by Type in 2017 Table Russia Insulin Like Growth Factor I Sales (K Units) by Applications (2012-2017) Table Russia Insulin Like Growth Factor I Sales (K Units) Market Share by Applications (2012-2017) Figure Russia Insulin Like Growth Factor I Sales (K Units) Market Share by Applications in 2017 Figure Italy Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017) Figure Italy Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Italy Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017) Table Italy Insulin Like Growth Factor I Sales (K Units) by Type (2012-2017) Table Italy Insulin Like Growth Factor I Sales (K Units) Market Share by Type (2012-2017) Figure Italy Insulin Like Growth Factor I Sales (K Units) Market Share by Type in 2017 Table Italy Insulin Like Growth Factor I Sales (K Units) by Applications (2012-2017) Table Italy Insulin Like Growth Factor I Sales (K Units) Market Share by Applications (2012-2017) Figure Italy Insulin Like Growth Factor I Sales (K Units) Market Share by Applications in 2017 Figure Benelux Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017) Figure Benelux Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Benelux Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017) Table Benelux Insulin Like Growth Factor I Sales (K Units) by Type (2012-2017) Table Benelux Insulin Like Growth Factor I Sales (K Units) Market Share by Type (2012-2017) Figure Benelux Insulin Like Growth Factor I Sales (K Units) Market Share by Type in 2017 Table Benelux Insulin Like Growth Factor I Sales (K Units) by Applications (2012-2017) Table Benelux Insulin Like Growth Factor I Sales (K Units) Market Share by Applications (2012-2017) Figure Benelux Insulin Like Growth Factor I Sales (K Units) Market Share by Applications in 2017 Figure Spain Insulin Like Growth Factor I Sales (K Units) and Growth Rate (2012-2017) Figure Spain Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Spain Insulin Like Growth Factor I Sales Price (USD/Unit) Trend (2012-2017) Table Spain Insulin Like Growth Factor I Sales (K Units) by Type (2012-2017) Table Spain Insulin Like Growth Factor I Sales (K Units) Market Share by Type (2012-2017) Figure Spain Insulin Like Growth Factor I Sales (K Units) Market Share by Type in 2017 Table Spain Insulin Like Growth Factor I Sales (K Units) by Applications (2012-2017) Table Spain Insulin Like Growth Factor I Sales (K Units) Market Share by Applications (2012-2017) Figure Spain Insulin Like Growth Factor I Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Europe Insulin Like Growth Factor I Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Insulin Like Growth Factor I Price and Trend Forecast (2018-2023) Table Europe Insulin Like Growth Factor I Sales (K Units) Forecast by Regions (2018-2023) Figure Europe Insulin Like Growth Factor I Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Europe Insulin Like Growth Factor I Sales (K Units) Market Share Forecast by Regions in 2023 Table Europe Insulin Like Growth Factor I Revenue (Million USD) Forecast by Regions (2018-2023) Figure Europe Insulin Like Growth Factor I Revenue Market Share Forecast by Regions (2018-2023) Figure Europe Insulin Like Growth Factor I Revenue Market Share Forecast by Regions in 2023 Figure Germany Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Germany Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure France Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure France Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure UK Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure UK Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Russia Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Russia Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Italy Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Italy Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Spain Insulin Like Growth Factor I Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Spain Insulin Like Growth Factor I Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Europe Insulin Like Growth Factor I Sales (K Units) Forecast by Type (2018-2023) Figure Europe Insulin Like Growth Factor I Sales Market Share Forecast by Type (2018-2023) Table Europe Insulin Like Growth Factor I Revenue (Million USD) Forecast by Type (2018-2023) Figure Europe Insulin Like Growth Factor I Revenue Market Share Forecast by Type (2018-2023) Table Europe Insulin Like Growth Factor I Price (USD/Unit) Forecast by Type (2018-2023) Table Europe Insulin Like Growth Factor I Sales (K Units) Forecast by Application (2018-2023) Figure Europe Insulin Like Growth Factor I Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Boehringer Ingelheim GmbH Genervon Biopharmaceuticals LLC MedImmune LLC Regulaxis SAS ... ...